Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction notice to"Nitric oxide sensing by chlorophyll a" [Anal. Chim. Acta 985 (2017) 101-113].

Analytica chimica acta·2026
Same author

New thalassemia mutations from West Bengal.

The Indian journal of medical research·2026
Same author

Letter to editor: Re: "Prevalence of HIV, hepatitis B and hepatitis C infections among patients with thalassemia attending a tertiary care (rural) hospital".

Journal of family medicine and primary care·2025
Same author

Infrared thermography: An investigative tool for detection of subclinical bleed in hemophilia on prophylaxis.

The Indian journal of medical research·2024
Same author

Multifaceted perspectives of detecting and targeting solid tumors.

International review of cell and molecular biology·2024
Same author

Thalidomide and Hydroxyurea in Transfusion-Dependent Thalassemia: Efficacy, Safety Profile and Impact on Quality of Life.

Hemoglobin·2024

Related Experiment Video

Updated: May 10, 2026

An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers
05:43

An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers

Published on: November 8, 2024

Drug delivery using platelet cancer cell interaction.

Sounik Sarkar1, Mohammed Aftab Alam, Jyoti Shaw

  • 1Department of Biochemistry, University of Calcutta, 35 Ballygunge Circular Road, Kolkata, 700019, India.

Pharmaceutical Research
|June 7, 2013
PubMed
Summary

Platelets can be engineered to deliver anticancer drugs directly to cancer cells, improving treatment efficacy. This targeted platelet drug delivery system shows higher cytotoxicity than free drugs in both lab and animal models.

More Related Videos

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

Related Experiment Videos

Last Updated: May 10, 2026

An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers
05:43

An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers

Published on: November 8, 2024

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

Area of Science:

  • Biotechnology
  • Nanomedicine
  • Cancer Therapeutics

Background:

  • Effective cancer treatment relies on targeted drug delivery to minimize side effects and maximize efficacy.
  • Platelets, natural blood components, exhibit an inherent affinity for cancer cells, presenting a potential drug delivery vehicle.
  • Developing biocompatible and efficient drug carriers is crucial for advancing cancer therapy.

Purpose of the Study:

  • To develop a novel, biocompatible, and targeted drug delivery system utilizing platelets as carriers for anticancer drugs.
  • To investigate the efficacy of platelet-mediated drug delivery in both in vitro and in vivo cancer models.

Main Methods:

  • Doxorubicin hydrochloride, an anticancer agent, was loaded onto platelets.
  • The efficacy of drug-loaded platelets was evaluated using a lung adenocarcinoma cell line (A549) in vitro.
  • The system's effectiveness was further assessed in Ehrlich ascites carcinoma (EAC) bearing mice, with and without platelets.

Main Results:

  • Platelets demonstrated the ability to uptake and release doxorubicin hydrochloride upon activation.
  • Drug-loaded platelets exhibited significantly higher cytotoxicity compared to free doxorubicin hydrochloride in both in vitro and in vivo models.
  • Targeted delivery via platelets enhanced the therapeutic effect of the anticancer drug.

Conclusions:

  • Platelet-mediated drug delivery offers a promising strategy for improved cancer treatment management.
  • This approach allows for targeted drug delivery at lower concentrations, potentially reducing systemic toxicity.
  • The personalized nature of using a patient's own platelets enhances the potential for clinical application and drug delivery customization.